An open-label, single-arm, phase I study to assess the safety, efficacy, and biomarker effects of OMT-110 in patients with refractory colorectal cancer.

Park, Soobong; Lee, Haejun; Jeong, Keun-Yeong; Baek, Jeong-Heum; Chang, Chong-Hwan

Detailed Information

Cited 0 time in webofscience

Cited 0 time in scopus

Metadata Downloads

An open-label, single-arm, phase I study to assess the safety, efficacy, and biomarker effects of OMT-110 in patients with refractory colorectal cancer.

Authors: Park, Soobong; Lee, Haejun; Jeong, Keun-Yeong; Baek, Jeong-Heum; Chang, Chong-Hwan

Issue Date: May-2020

Publisher: LIPPINCOTT WILLIAMS & WILKINS

Citation: JOURNAL OF CLINICAL ONCOLOGY, v.38, no.15

Journal Title: JOURNAL OF CLINICAL ONCOLOGY

Volume: 38

Number: 15

URI: https://scholarworks.bwise.kr/gachon/handle/2020.sw.gachon/80261

ISSN: 0732-183X

Files in This Item: There are no files associated with this item.

Appears in Collections: 의과대학 > 의학과 > 1. Journal Articles

Show full item record

qrcode

Related Researcher

Researcher Baek, Jeong-Heum photo

Baek, Jeong-Heum: College of Medicine (Department of Medicine)

Read more

Altmetrics

Total Views & Downloads

STATISTICS: Total View :4,139,828; Today View :1,675

RSS_1.0 RSS_2.0 ATOM_1.0

1342, Seongnam-daero, Sujeong-gu, Seongnam-si, Gyeonggi-do, Republic of Korea(13120)031-750-5114

Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.

Detailed Information

Related Researcher

Altmetrics

Total Views & Downloads

BROWSE